glp 1 statistics Obesity GLP-1 Market GLP-1 Receptor Agonist Market Size,

Data availability The full set of de-identified summary statistics can be made available to qualified investigators who enter into an agreement with 23andMe that protects participant confidentiality

Start at the lower end of the dosing range to assess individual response

It works on a cellular level to help your body repair tissues, reduce inflammation, and even protect the gut lining

CVS Caremark selected Wegovy as its preferred GLP-1 for weight loss effective July 1, 2025, removing Zepbound from these formulary types: [2] Standard Control Formulary Most common employer formulary Advanced Control Formulary More restrictive formulary with lower premiums Value Formulary Cost-focused formulary used by smaller employers Background: The Zepbound Class Action Lawsuits In September 2025, two class action lawsuits were filed by Zepbound patients against CVS Caremark: [3][8] (Sept